CTIS2023-508148-23-01
Active, not recruiting
Phase 1
Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentre, randomized study comparing two durations of dual antiplatelet therapy - Etude DAPT-CTO
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Enrollment
- 660
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who underwent a successful coronary stent implantation for chronic coronary occlusion, eligible for long\-term aspirin therapy and requiring a dual antiplatelet therapy, Affiliated to Social Security system, Signature of informed consent, Age \> 18 years old
Exclusion Criteria
- •Dual antiplatelet therapy contra\-indication, Patient with hypersensitivity to aspirin (or any of its excipients) and/or to any of the active substance or to any of the excipients of the investigational medical product used in this study (clopidogrel), Patient with contraindication to aspirin and/or clopidogrel, No coronary stent implanted, Age\<18years, Patient under guardianship, Pregnancy or breast feeding, Prasugrel or ticagrelor use
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Perioperative Antiplatelet therapy in patients with drug-eluting Stent undergoing noncardiac SURgEryKCT0002907Asan Medical Center1,000
Completed
Phase 4
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioNL-OMON45158Sint Antonius Ziekenhuis500
Active, not recruiting
Phase 1
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic stenosis for which a transcatheter aortic valve implantation (TAVI) is performed.MedDRA version: 19.1Level: PTClassification code 10002906Term: Aortic stenosisSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2013-003125-28-GBSt. Antonius Hospital1,000
Recruiting
Not Applicable
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic valve diseaseaortic valve stenosisbleedingstrokethrombosisplatelet inhibitors.NL-OMON25546St Antonius Hospital, Nieuwegein, the Netherlands1,000
Active, not recruiting
Phase 1
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioEUCTR2013-003125-28-BESt. Antonius Hospital1,000